by Alena Morrison

Prof. Gabriel P. Krestin has assumed the role of scientific director of the European Institute for Biomedical Imaging Research (EIBIR) after being nominated for the role during the organisation’s General Meeting on Saturday, March 8.

Committed to radiology research, Krestin worked with the ESR to establish EIBIR, which aims to foster and strengthen biomedical imaging research in Europe and has been involved with the organisation since its founding in 2006. He also recently served as chairman of the General Meeting. Since its inception, EIBIR has developed into a key platform for supporting research networking activities, spreading good practice and promoting common initiatives and interoperability in the field of biomedical imaging research. Stakeholders in the EIBIR network have also continued to grow and include European research institutes, shareholder organisations and industry partners.

ECR Today spoke with Krestin to hear some of his thoughts about EIBIR and his ideas for the future of the organisation.

ECR Today: Looking towards 2014, what activities and initiatives would you like to see begin this year?

Gabriel Krestin: We will have to strengthen the strategy and further extend the activities of EIBIR in the coming years. For now, I hope that at least some of the applications to the first call for proposals in the Horizon 2020 research funding framework of the EC will go into the second phase. That would keep the EIBIR office very busy in the coming months but would also give a new boost to EIBIR’s role as coordinator and administrator of biomedical imaging research in Europe. Furthermore, I hope that some new joint research initiatives will start in image-guided interventions, radiation therapy, paediatric imaging, and neuroimaging. Moreover, the intention is to set up a virtual contract research organisation that will enable multicentre imaging trials, initiated by researchers or by industry, to be performed.

Read more…

As acknowledged in last year’s ESR white paper on the subject, the concept of personalised medicine (PM) is becoming an increasingly hot topic. The patient-centred principles of PM have the potential to take over as the dominant philosophy in clinical healthcare in the relatively near future, which would see the focus of the medical world gradually shifting away from the current system of ‘disease care’, towards an approach based on prediction and prevention. However, although most radiologists are aware of the idea of PM and rightly consider medical imaging to already be among the most personalised aspects of healthcare, there is perhaps a need for more awareness of the exact nature of this new paradigm, and specifically a need for recognition – from within and outside the discipline – of the role that medical imaging should play.

ESR President Prof. Gabriel P. Krestin will chair the Professional Challenges Session on personalised medicine

A Professional Challenges Session at ECR 2013, chaired by the ESR President, Prof. Gabriel Krestin, will aim to raise awareness of the core principles of PM and highlight the factors that radiologists will need to consider in order to adapt their approach to training, clinical practice and research.

“The whole idea of PM, and the role of imaging within it, is relevant to all of us,” said Krestin, from the Erasmus Medical Centre, Rotterdam, Netherlands. “It is a concept that will gain in importance in the coming years and it will have an increasing influence on the way we work as radiologists. I think many people have heard of PM, but certainly not everyone will have a sound conception of exactly what it is or its full implications for imaging and our daily practice. To be aware of this, and the possibilities that will probably multiply in the coming years, is very important.”

Read more…